Home › Markets › Health Care › ISRG

Intuitive Surgical Inc. (ISRG)

ISRG trades on Nasdaq in Health Care, Industrial Specialties. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$422.06
-1.30% on the day
Market cap
$149.1B
Large cap
Revenue · 2025
$10.1B
+20.5% on 2024
Net income · 2025
$2.9B
28.4% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.

Profile

FieldValue
TickerISRG on Nasdaq
SectorHealth Care
IndustryIndustrial Specialties
CountryUnited States
IPO year2000
SEC CIK0001035267
SEC industry codeOrthopedic, Prosthetic & Surgical Appliances & Supplies
Incorporated inDE

Financials · 2025

LineValue
Revenue$10.1B
Net income$2.9B
Operating income$2.9B
Net margin28.4%
Operating margin29.3%
Revenue growth+20.5%
Cash$3.4B
Total assets$20.5B
P/E (computed)52.2×
P/S (computed)14.8×

Key SEC documents

DocumentFormFiled
Latest annual report10-K2026-02-03
Latest quarterly / interim10-Q2026-07-21
Latest current report8-K2026-07-27
Latest proxyDEFA14A2026-03-13

Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week+1.1%
1 month+11.1%
3 months+4.2%
Year to date-26.0%
1 year-3.8%
From 52-week high-29.3%

Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Industrial Specialties

TickerCompanyPriceDayMarket cap
EWEdwards Lifesciences Corporation$85.27-1.30%$49.1B
STESTERIS plc (Ireland)$217.77-0.55%$21.2B
ZBHZimmer Biomet Holdings Inc.$92.08-0.10%$17.6B
MASMasco Corporation$69.74+1.10%$13.8B
AITApplied Industrial Technologies Inc.$332.85-0.29%$12.2B
SNNSmith & Nephew SNATS Inc.$27.86+0.69%$11.7B
ALGNAlign Technology Inc.$143.54+2.22%$10.2B
MSAMSA Safety Incorporated$181.79-0.11%$7.0B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier